The outcomes of transcatheter aortic valve replacement in a cohort of patients with end‐stage renal disease

ConclusionsPatients with ESRD who undergo TAVR are at high risk for mortality and complications. TAVR outcomes are comparable to but not substantially better than those with SAVR. Transfemoral TAVR seems to be at least as safe and effective as the current standard SAVR in patients undergoing aortic valve replacement. © 2016 Wiley Periodicals, Inc.

Source: Catheterization and Cardiovascular Interventions - March 4, 2016 Category: Cardiovascular & Thoracic Surgery Authors: Molly Szerlip, Rebeca J. Kim, Tokunbo Adeniyi, Vinod Thourani, Vasilis Babaliaros, Joseph Bavaria, Howard C. Herrmann, Saif Anwaruddin, Raj Makkar, Tarun Chakravarty, Joshua Rovin, Don Creighton, D. Craig Miller, Kim Baio, Elizabeth Walsh, Jasmina Katinic Tags: Valvular and Structural Heart Diseases Source Type: research